As of the latest Form 4 filed Jun 2, 2026.
What Caris Life Sciences, Inc. Common Stock insiders — officers, directors and 10% owners — have bought and sold in their own stock, straight from their SEC Form 4 filings. Values are shares × the reported transaction price where both are disclosed.
Buys plotted up, sells down; bar height is the disclosed dollar value (shares × reported price). Our Form 4 history is only complete from mid-2026, so early months are sparse — the series fills in as more filings land. Open-market purchases and sales only.
Newest filing first — the 19 most recent filings for CAI.
| Filed | Trade date | Insider | Transaction | Shares | Price | Value | 10b5-1 | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-02 | 2026-05-29 | Knowles Jonathan Kenneth Charles Director | AAward | +1.60K | $15.62 | $25.0K | No | Form 4 ↗ |
| 2026-06-02 | 2026-05-29 | POSTE GEORGE Director | AAward | +1.60K | $15.62 | $25.0K | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | Power Luke Thomas See Remarks | FTax | −9.77K | $15.25 | $149K | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | Brille Brian J See Remarks | FTax | −14.0K | $15.25 | $213K | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | Spetzler David Baxley President | FTax | −13.9K | $15.25 | $211K | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | Denton John Russel See Remarks | FTax | −6.05K | $15.25 | $92.2K | No | Form 4 ↗ |
| 2026-05-18 | 2026-05-15 | HALBERT DAVID D See Remarks | FTax | −40.7K | $15.25 | $621K | No | Form 4 ↗ |
| 2026-05-12 | 2026-05-11 | Vacirca Jeff L Director | PPurchase | +31.1K | $16.15 | $501K | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Power Luke Thomas See Remarks | AAward | +64.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Brille Brian J See Remarks | AAward | +83.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Spetzler David Baxley President | AAward | +83.2K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | Denton John Russel See Remarks | AAward | +64.0K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-10 | 2026-03-06 | HALBERT DAVID D See Remarks | AAward | +320K | $0.00 | $0.00 | No | Form 4 ↗ |
| 2026-03-02 | 2026-02-26 | Minor Lloyd Director | AAward | +2.49K | $20.06 | $50.0K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Fredrickson David Paul Director | AAward | +2.49K | $20.06 | $50.0K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | Vacirca Jeff L Director | AAward | +2.49K | $20.06 | $50.0K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | PHILLIPS T DANNY Director | AAward | +3.74K | $20.06 | $75.0K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | CASTLEMAN PETER M Director | AAward | +5.51K | $20.06 | $111K | No | Form 4 ↗ |
| 2026-02-27 | 2026-02-26 | HALBERT JON Director | AAward | +2.49K | $20.06 | $50.0K | No | Form 4 ↗ |
Insiders — a company’s officers, directors and holders of more than 10% of its stock — must report any trade in that stock to the SEC on a Form 4 within two business days. Each row here is one transaction from those filings.
The transaction code tells you what happened: Purchase (P) and Sale (S) are open-market trades — the ones markets watch most; Award (A) is a granted stock or unit, Option exercise (M) converts options into shares, and Gift (G) is a transfer for no consideration. Awards, exercises and gifts are largely compensation or administrative, not a directional bet.
One caveat on sales: many are made under a Rule 10b5-1 plan scheduled months in advance, so a sale is not automatically a bearish signal. Insider activity is a noisy input — read it alongside the filings, not on its own.
See also CAI’s full analysis or the market-wide insider trading feed. The tabs above jump to CAI’s other SEC data.
Source: SEC Form 4 filings for CAI, parsed from EDGAR. Transaction prices are as reported in the filing — SEC public-domain data, not market quotes. Values are shares × reported price where both are disclosed; grants and gifts often carry no price. A delayed record of what insiders reported, not a live position or a recommendation.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.